| URN | urn:agi-llid:338 |
|---|---|
| Name | APOB |
| Description | apolipoprotein B (including Ag(x) antigen) |
| Connectivity | 441 |
| Notes | This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq] |
| Swiss-Prot Accession | P04114 |
|---|---|
| P78482 | |
| Q13789 | |
| Q13828 | |
| Q4ZG63 | |
| Q53QC8 | |
| Q59HB3 | |
| Q7Z7Q0 | |
| Q9UE51 | |
| Q9UE52 | |
| Q9UE53 | |
| Q3UH74 | |
| Q497D8 | |
| Q61314 | |
| Q61318 | |
| Q8CGG8 | |
| Q7TMA5 | |
| Q4G047 | |
| Q62970 | |
| Q63050 | |
| Q63051 | |
| Q63052 | |
| Q64721 | |
| Q78EF2 |
| Unigene ID | Hs.120759 |
|---|---|
| Mm.221239 | |
| Rn.33815 |
| KEGG ID | hsa:338 |
|---|---|
| mmu:238055 | |
| rno:54225 |
| EC Number | 3.5.4.5 |
|---|
| Swiss-Prot ID | APOB_HUMAN |
|---|---|
| APOB_RAT | |
| Q3UH74_MOUSE |
| Cell Localization | Plasma membrane |
|---|
| GO ID | 0017127 |
|---|---|
| 0008201 | |
| 0005319 | |
| 0050750 | |
| 0005543 | |
| 0046982 | |
| 0048844 | |
| 0042632 | |
| 0008203 | |
| 0030301 | |
| 0009566 | |
| 0001701 | |
| 0016042 | |
| 0006869 | |
| 0042158 | |
| 0042159 | |
| 0042953 | |
| 0034383 | |
| 0034374 | |
| 0007399 | |
| 0010744 | |
| 0045834 | |
| 0009791 | |
| 0045540 | |
| 0030317 | |
| 0007283 | |
| 0008202 | |
| 0019433 | |
| 0006642 | |
| 0034379 | |
| 0034360 | |
| 0030669 | |
| 0005783 | |
| 0005788 | |
| 0031904 | |
| 0010008 | |
| 0005576 | |
| 0034363 | |
| 0034362 | |
| 0034359 | |
| 0005792 | |
| 0005886 | |
| 0034361 | |
| 0006629 | |
| 0042157 | |
| 0008289 | |
| 0005515 | |
| 0009743 | |
| 0010033 | |
| 0010269 | |
| 0042627 | |
| 0005615 | |
| 0005634 | |
| 0031983 | |
| 0012506 |
| Pathway | PPARbeta Targets |
|---|
| IPI ID | IPI00022229 |
|---|---|
| IPI00894122 | |
| IPI00553336 | |
| IPI00666034 | |
| IPI00555161 | |
| IPI00554264 |
| Ariadne Ontology | Lipid transport |
|---|
| Mouse chromosome position | 12 A1.1 |
|---|
| GO Molecular Function | protein binding |
|---|---|
| lipid binding | |
| heparin binding | |
| phospholipid binding | |
| protein heterodimerization activity | |
| low-density lipoprotein receptor binding | |
| lipid transporter activity | |
| cholesterol transporter activity |
| Homologene ID | 328 |
|---|
| Hugo ID | 603 |
|---|
| GO Cellular Component | extracellular region |
|---|---|
| microsome | |
| vesicle membrane | |
| clathrin-coated endocytic vesicle membrane | |
| endoplasmic reticulum | |
| endosome lumen | |
| endosome membrane | |
| nucleus | |
| endoplasmic reticulum lumen | |
| plasma membrane | |
| extracellular space | |
| chylomicron | |
| low-density lipoprotein particle | |
| chylomicron remnant | |
| mature chylomicron | |
| intermediate-density lipoprotein particle | |
| very-low-density lipoprotein particle | |
| vesicle lumen |
| MGI ID | 88052 |
|---|
| Human chromosome position | 2p24-p23 |
|---|
| GO Biological Process | very-low-density lipoprotein particle assembly |
|---|---|
| positive regulation of foam cell differentiation | |
| positive regulation of lipid metabolic process | |
| regulation of cholesterol biosynthetic process | |
| cholesterol homeostasis | |
| sperm motility | |
| low-density lipoprotein particle clearance | |
| low-density lipoprotein particle remodeling | |
| cholesterol metabolic process | |
| steroid metabolic process | |
| lipoprotein biosynthetic process | |
| triglyceride catabolic process | |
| triglyceride mobilization | |
| lipoprotein metabolic process | |
| lipoprotein catabolic process | |
| post-embryonic development | |
| artery morphogenesis | |
| nervous system development | |
| in utero embryonic development | |
| lipoprotein transport | |
| lipid transport | |
| cholesterol transport | |
| lipid catabolic process | |
| lipid metabolic process | |
| fertilization | |
| spermatogenesis | |
| response to organic substance | |
| response to selenium ion | |
| response to carbohydrate stimulus |
| Rat chromosome position | 6q14 |
|---|
| Group | Lipid transport |
|---|---|
| extracellular region | |
| microsome | |
| vesicle membrane | |
| clathrin-coated endocytic vesicle membrane | |
| endoplasmic reticulum | |
| endosome lumen | |
| endosome membrane | |
| nucleus | |
| endoplasmic reticulum lumen | |
| plasma membrane | |
| extracellular space | |
| chylomicron | |
| low-density lipoprotein particle | |
| chylomicron remnant | |
| mature chylomicron | |
| intermediate-density lipoprotein particle | |
| very-low-density lipoprotein particle | |
| vesicle lumen | |
| protein binding | |
| lipid binding | |
| heparin binding | |
| phospholipid binding | |
| protein heterodimerization activity | |
| low-density lipoprotein receptor binding | |
| lipid transporter activity | |
| cholesterol transporter activity | |
| very-low-density lipoprotein particle assembly | |
| positive regulation of foam cell differentiation | |
| positive regulation of lipid metabolic process | |
| regulation of cholesterol biosynthetic process | |
| cholesterol homeostasis | |
| sperm motility | |
| low-density lipoprotein particle clearance | |
| low-density lipoprotein particle remodeling | |
| cholesterol metabolic process | |
| steroid metabolic process | |
| lipoprotein biosynthetic process | |
| triglyceride catabolic process | |
| triglyceride mobilization | |
| lipoprotein metabolic process | |
| lipoprotein catabolic process | |
| post-embryonic development | |
| artery morphogenesis | |
| nervous system development | |
| in utero embryonic development | |
| lipoprotein transport | |
| lipid transport | |
| cholesterol transport | |
| lipid catabolic process | |
| lipid metabolic process | |
| fertilization | |
| spermatogenesis | |
| response to organic substance | |
| response to selenium ion | |
| response to carbohydrate stimulus |
| RGD ID | 2129 |
|---|
| LocusLink ID | 338 |
|---|---|
| 238055 | |
| 54225 |
| Alias | FLDB |
|---|---|
| apolipoprotein B | |
| apoB-48 | |
| apoB-100 | |
| OTTHUMP00000115994 | |
| apolipoprotein B48 | |
| AI315052 | |
| MGC176318 | |
| mCG_129875 | |
| Aa1064 | |
| Ac1-060 | |
| apolipoprotein B PI | |
| apolipoprotein B-48 | |
| apolipoprotein B-100 | |
| Apo B-100 | |
| Apolipoprotein B-100 precursor | |
| APOB | |
| apolipoprotein B (including Ag(x) antigen) | |
| AA-1064 | |
| AA(1064) | |
| AA 1064 | |
| apo B | |
| apoB-48s |
| Organism | Homo sapiens |
|---|---|
| Mus musculus | |
| Rattus norvegicus |
| OMIM ID | 107730 |
|---|---|
| 144010 |